Harbor Investment Advisory, LLC Chemo Centryx, Inc. Transaction History

Harbor Investment Advisory, LLC

$1.19 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Jul 27, 2021	SELL	$9.59 - $50.88 $10,462 - $55,510	-1,091 Closed	0 $0
Q1 2021 Apr 16, 2021	BUY	$49.53 - $68.4 $11,887 - $16,416	240 Added 28.2%	1,091 $56,000
Q4 2020 Feb 04, 2021	BUY	$47.25 - $65.16 $15,639 - $21,567	331 Added 63.65%	851 $53,000
Q3 2020 Oct 23, 2020	BUY	$46.35 - $61.69 $17,427 - $23,195	376 Added 261.11%	520 $28,000
Q2 2020 Jul 16, 2020	BUY	$38.58 - $65.07 $154 - $260	4 Added 2.86%	144 $8,000
Q1 2020 May 11, 2020	BUY	$32.73 - $50.78 $4,582 - $7,109	140 New	140 $6,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbor Investment Advisory, LLC with notifications on news.